Brain

Neurophet to Participate in SNMMI 2025: Showcasing ‘Neurophet SCALE PET’ and Expanding Global Partnerships

Showcasing brain imaging analysis solutions such as Neurophet SCALE PET, which provides SUVR values for PET tracersEngaging in partnering discussions…

7 months ago

Biomarkers and New Therapeutic Strategies to Better Treat Brain Cancer

INRS Professor receives $1.2M to advance glioblastoma research  LAVAL, QC, June 20, 2025 /CNW/ - Professor Maya Saleh, a world-renowned expert in…

7 months ago

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients

– Research supports combined use of EEG/ERP and vMRI for accurate differential diagnosis of SCD, MCI and dementia – –…

7 months ago

Axsome Therapeutics Champions Brain Health During Alzheimer’s & Brain Awareness Month

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…

7 months ago

CHMP recommends third indication for darolutamide for patients with advanced prostate cancer

ORION CORPORATION PRESS RELEASE 20 JUNE 2025 at 13.30 EEST           CHMP recommends third indication for darolutamide for patients with advanced…

7 months ago

Approved by Health Canada – Zilia Ocular: A World First Set to Revolutionize Eye Care

QUEBEC CITY, June 19, 2025 /PRNewswire/ - Zilia, a Canadian health technology company, is proud to announce that its flagship…

7 months ago

Happy Ring Earns Second FDA Clearance–Now Approved for At-Home Sleep Testing to Simplify the Diagnosis and Treatment of Sleep Apnea and Related Health Conditions

First FDA-cleared smart ring for multi-night sleep testing and 24/7 biometrics — to catch disease early—years before standard care. AUSTIN,…

7 months ago

Red Light Holland Partners with Arizona State University to Support Groundbreaking Psychedelic Genome Project (PGP) Research Study

Toronto, Ontario--(Newsfile Corp. - June 19, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light…

7 months ago

Theranica to Present Three Real-World Evidence Studies at AHS Scientific Meeting Highlighting the Impact of the Nerivio® REN Wearable on Migraine Treatment

New studies confirm the clear benefit of early acute treatment, the consistent effectiveness of REN over years, and its clinical…

7 months ago

dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply

Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapiesDURHAM, N.C. and WEST VALLEY CITY, Utah, June…

7 months ago